Recommendation based on LAURA Phase III trial results which showed Tagrisso extended median progression-free survival to more than three years
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
Emraclidine was well-tolerated with an adverse event profile consistent with Phase 1b trial
In Q2 FY25, our crop protection segment reported revenue of Rs. 159 crore, with an EBIT margin of 5%
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
Max Healthcare Institute has reported total income of Rs. 1,748.30 crores during the period ended September 30, 2024
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth
The group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode
Subscribe To Our Newsletter & Stay Updated
